183 related articles for article (PubMed ID: 16393687)
21. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
22. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
23. Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia.
Wong KF; So CC; Chan JK
Am J Clin Pathol; 2002 Feb; 117(2):246-51. PubMed ID: 11865846
[TBL] [Abstract][Full Text] [Related]
24. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
25. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
[TBL] [Abstract][Full Text] [Related]
26. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
27. B lymphocytes in humans express ZAP-70 when activated in vivo.
Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
[TBL] [Abstract][Full Text] [Related]
28. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
[TBL] [Abstract][Full Text] [Related]
30. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
[TBL] [Abstract][Full Text] [Related]
32. [Expression and role of cyclin D3 in childhood acute leukemia].
Zhang L; Li J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):347-9. PubMed ID: 11721429
[TBL] [Abstract][Full Text] [Related]
33. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
Vasef MA; Medeiros LJ; Koo C; McCourty A; Brynes RK
Am J Clin Pathol; 1997 Sep; 108(3):302-7. PubMed ID: 9291459
[TBL] [Abstract][Full Text] [Related]
35. Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes!
Lima M; Pinto L; Dos Anjos Teixeira M; Canelhas A; Mota A; Cabeda JM; Silva C; Queirós ML; Fonseca S; Santos AH; Brochado P; Justiça B
Cytometry B Clin Cytom; 2003 Jan; 51(1):41-4. PubMed ID: 12500296
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
37. Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia.
Preobrazhensky SN; Bahler DW
Cytometry B Clin Cytom; 2008 Mar; 74(2):118-27. PubMed ID: 17948236
[TBL] [Abstract][Full Text] [Related]
38. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically.
Frater JL; McCarron KF; Hammel JP; Shapiro JL; Miller ML; Tubbs RR; Pettay J; Hsi ED
Am J Clin Pathol; 2001 Nov; 116(5):655-64. PubMed ID: 11710681
[TBL] [Abstract][Full Text] [Related]
39. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
40. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
